Summary
Antibodies to rheumatoid arthritis nuclear antigen (RANA) are four- to sixfold increased in sera from patients with rheumatoid arthritis (RA), whereas levels of antibodies to other EBV encoded antigens are slightly elevated or normal. We have demonstrated that the major epitopes recognised by anti-RANA antibodies are represented by a synthetic peptide, P62, corresponding to part of the internal repeat sequence which contains only the amino acids glycine and alanine. In an enzyme-linked immunosorbent assay, anti-P62 antibodies in rheumatoid arthritis sera were four fold higher than healthy and disease controls. By contrast, levels of antibodies to a cloned fusion protein, representing the C-terminus of EBNA-1 and excluding the IR3 region, were normal in RA, but elevated fivefold in nasopharyngeal carcinoma (NPC). Affinity purified anti-P62 antibodies reacted with EBNA-1 and RANA but also with a 60 kD protein present in tissue extracts which has been tentatively identified as cytokeratin. This suggests that the specific increase of anti-P62 antibodies in RA may be due to cross-reactions with autoantibodies to structural proteins with repeat sequences containing glycine. Such sequences are found in cytokeratin and proteoglycans, suggesting that anti-P62 (and hence anti-RANA) antibodies may be cross-reactive antibodies of pathogenic significance in RA, though not necessarily indicating an aetiological role for EBV.
Similar content being viewed by others
References
Alspaugh MA, Tan EM (1976) Serum antibody in rheumatoid arthritis reactive with a cell associated antigen. Arthritis Rheum 19:711–719
Alspaugh MA, Jensen FC, Rabin H, Tan EM (1978) Lymphocytes transformed by EB virus: induction of nuclear antigen reactive with serum antibody in rheumatoid arthritis. J Exp Med 147:1018–1027
Elson CJ, Crawford DM, Bucknall RC, Allen C, Thomson JL, Hall ND, Bacon PA, Epstein MA (1979) Infection with EB virus and rheumatoid arthritis. Lancet I:105
Venables PJW, Roffe LM, Erhardt CC, Maini RN, Edwards JMB, Porter AD (1981) Titers of antibodies to RANA in rheumatoid arthritis and normal sera: relationship to Epstein-Barr virus infection. Arthritis Rheum 24:1459–1464
Phillips PE, Lim WN, Parkman PD, Harshut Y (1973) Virus antibody and IgG levels in juvenile rheumatoid arthritis. Arthritis Rheum 19:711–719
Gear AJ, Venables PJW, Edwards JMB, Maini RN, Ansell BM (1986) Rheumatoid arthritis, juvenile chronic arthritis, iridocyclitis and the Epstein-Barr virus. Ann Rheum Dis 45:6–8
Bardwick PA, Bluestein HG, Zwaifler NH, Depper JM, Seegmiller JE (1980) Altered regulation of Epstein-Barr virus induced lymphoblast proliferation in RA is due to a T-cell defect. J Immunol 127:1899–1902
Tosato G, Steinberg AD, Blaese RM (1981) Defective Epstein-Barr virus specific suppressor T-cell function in rheumatoid arthritis. N Engl J Med 305:1238–1243
Tosato G, Blaese RM (1985) Epstein-Barr virus infection and immunoregulation in Man. In: Dixon FJ (ed) Advances in immunology, vol 37. Academic Press, New York, pp 99–149
Tosato G, Steinberg AD, Yarchoan R, Heilman CA, Pike SE, De Seau V, Blaese RM (1984) Abnormally elevated frequency of Epstein-Barr virus-infected cells in the blood of patients with rheumatoid artritis. J Clin Invest 73:1789–1995
Alspaugh MA, Henle G, Lennette ET, Henle W (1981) Elevated levels of antibodies to Epstein-Barr virus antigens in patients with rheumatoid arthritis. J Clin Invest 67:1134–1140
Ferrel FB, Aitcheson CT, Pearson GR, Tan EM (1981) Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis. J Clin Invest 67:681–687
Catalano MA, Carson DA, Slovin SF, Richaman DD, Vaughan JH (1979) Antibodies to Epstein-Barr virus determined antigens in normal subjects and patients with seropositive rheumatoid arthritis. Proc Natl Acad Sci USA 76:681–687
Venables PJW, Ross MGR, Charles PJ, Melsom RD, Griffiths PD, Maini RN (1985) A seroepidemiological study of cytomegalovirus and Epstein-Barr virus in rheumatoid arthritis and sicca syndrome. Ann Rheum Dis 44:742–746
Billings PB, Hoch SO, White PJ, Carson DA, Vaughan JH (1983) Antibodies to Epstein-Barr nuclear antigen and to the rheumatoid arthritis nuclear antigen identify the same polypeptide. Proc Natl Acad Sci USA 80:7104–7108
Venables PJW, Smith PR, Maini RN (1984) Rheumatoid arthritis nuclear antigen and Epstein-Barr virus. Arthritis Rheum 27:476–477
Venables PJW, Pawlowski T, Mumford PA, Brown C, Crawford DH, Maini RN (1988) Reaction of antibodies to rheumatoid arthritis nuclear antigen with a synthetic peptide corresponding to part of Epstein-Barr nuclear antigen-1. Ann Rheum Dis 47:270–279
Rhodes G, Carson DA, Valbract J, Houghten R, Vaughan JH (1985) Human immune responses to synthetic peptides from the Epstein-Barr nuclear antigen. J Immunol 134:211–216
Millman G, Scott Al, Cho M, Hartman SC, Ades DK, Hayward GS, Ki P, August JT, Hayward SD (1985) Carboxyl terminal domain of the Epstein-Barr virus nuclear antigen is highly immunogenic in man. Proc Natl Acad Sci USA 82:6300–6304
Ropes MW, Bennet GA, Cobb S, Jacox R, Jessar RA (1959) Revision of criteria for rheumatoid arthritis. Bull Rheum Dis 9:175–176
Williams DG, Stocks MR, Charles PJ, Maini RN (1986) Antibodies to La, Jo-1, nRNP and Sm detected by a multitrack immunoblotting using a novel filter holder: a comparative study with counter immunoelectrophoresis using sera from patients with systemic lupus erythematosus and Sjogren's syndrome. J Immunol Methods 91:65–7372
Fuchs E, Hanukoglu I (1983) Unravelling the structure of the intermediate filaments. Cell 34:332–334
Kataaha PK, Mortazavi-Milani SM, Russel G, Holborow EJ (1985) Anti-intermediate filament antibodies, anti-keratin antibody, and anti-perinuclear antibody in rheumatoid arthritis and infectious mononucleosis. Ann Rheum Dis 44:446–449
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baboonian, C., Halliday, D., Venables, P.J.W. et al. Antibodies in rheumatoid arthritis react specifically with the glycine alanine repeat sequence of Epstein-Barr nuclear antigen-1. Rheumatol Int 9, 161–166 (1989). https://doi.org/10.1007/BF00271874
Issue Date:
DOI: https://doi.org/10.1007/BF00271874